Acadia Healthcare Company, Inc. (ACHC)
$
21.59
+0.46 (2.13%)
Key metrics
Financial statements
Free cash flow per share
0.3441
Market cap
2 Billion
Price to sales ratio
0.6173
Debt to equity
0.7751
Current ratio
1.3205
Income quality
2.7967
Average inventory
2.9 Million
ROE
0.0456
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Acadia Healthcare Company, Inc. provides behavioral healthcare services across the United States and Puerto Rico, highlighting the company's operational efficiency with an EBITDA ratio of 0.19. The company's stock is identified with the symbol 'ACHC' in the market, allowing investors to track its performance effectively. Acadia reported a substantial revenue of $3,153,963,000.00 reflecting its strong market presence and ability to cater to diverse patient needs. The income before tax ratio stands at 0.11 illustrating the pre-tax margin and underlying profitability. Moreover, the company reported selling, general, and administrative expenses of $189,706,000.00 indicating its operational overhead costs as it manages a network of facilities that includes inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, Acadia operates 238 behavioral healthcare facilities with approximately 10,600 beds, demonstrating its commitment to offering comprehensive healthcare solutions. The stock is affordable at $24.08 making it suitable for budget-conscious investors looking for entry points in the market. With a high average trading volume of 2,052,375.00 the stock indicates strong liquidity, which appeals to active traders and long-term investors alike. With a mid-range market capitalization of $1,993,763,094.00 the company is a steady performer amidst market fluctuations. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape, addressing the growing need for mental health services. Acadia Healthcare belongs to the Healthcare sector, driving innovation and growth as it advances its mission to provide quality care and improve outcomes for its patients. This essential role in the behavioral healthcare field positions it favorably for continued success and relevance in a rapidly evolving industry.
Investing in Acadia Healthcare Company, Inc. (ACHC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict Acadia Healthcare Company, Inc. stock to fluctuate between $17.13 (low) and $82.41 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-08-20, Acadia Healthcare Company, Inc.'s market cap is $1,993,763,094, based on 92,346,600 outstanding shares.
Compared to Eli Lilly & Co., Acadia Healthcare Company, Inc. has a Lower Market-Cap, indicating a difference in performance.
To buy Acadia Healthcare Company, Inc. (ACHC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ACHC. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Acadia Healthcare Company, Inc.'s last stock split was 1:4 on 2011-11-01.
Revenue: $3,153,963,000 | EPS: $2.79 | Growth: -1,262.50%.
Visit https://www.acadiahealthcare.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $89.85 (2022-11-30) | All-time low: $17.13 (2025-08-06).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
ACHC beats Q2 earnings estimates despite lower average length of stay and higher expenses, thanks to increased patient days.
seekingalpha.com
Acadia Healthcare Company, Inc.'s Q2 results showed revenue growth and profitability, but ongoing DOJ/SEC investigations and Medicaid headwinds continue to weigh on sentiment. Despite ACHC undervaluation based on P/S and P/E ratios, I remain cautious due to persistent reputational issues and softness in Medicaid-driven business. Management is focused on growth and expansion, but legal costs, CFO resignation, and policy uncertainty present ongoing risks.
seekingalpha.com
Acadia Healthcare Company, Inc. (NASDAQ:ACHC ) Q2 2025 Earnings Conference Call August 6, 2025 9:00 AM ET Company Participants Christopher Howal Hunter - CEO & Director Heather Dixon - Chief Financial Officer Patrick Thomas Feeley - Senior Vice President of Investor Relations Conference Call Participants Albert J. William Rice - UBS Investment Bank, Research Division Matthew Dale Gillmor - KeyBanc Capital Markets Inc., Research Division Andrew Mok - Barclays Bank PLC, Research Division Philip Chickering - Deutsche Bank AG, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Raj Kumar - Stephens Inc., Research Division Benjamin Whitman Mayo - Leerink Partners LLC, Research Division Ryan M.
zacks.com
ACHC, BLCO and BBCP have been added to the Zacks Rank #5 (Strong Sell) List on July 30, 2025.
globenewswire.com
If you purchased or acquired stock in Acadia between February 28, 2020 to October 30, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
zacks.com
DDD, ACHC and BBCP have been added to the Zacks Rank #5 (Strong Sell) List on July 25, 2025.
zacks.com
ACHC, CNL and RDY have been added to the Zacks Rank #5 (Strong Sell) List on July 18, 2025.
zacks.com
ACHC, CTEV and CNL have been added to the Zacks Rank #5 (Strong Sell) List on July 16, 2025.
zacks.com
Investors need to pay close attention to ACHC stock based on the movements in the options market lately.
seekingalpha.com
“One Big Beautiful Bill” inches closer to becoming law. It will have an impact on the broader economy, and especially certain specific sectors. Some dividend stocks could be in serious trouble, while others could gain. I share my take as a dividend investor.
See all news